Trade Universal Health Services - UHS CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.44 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Universal Health Services Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 181.71 |
Open* | 181.35 |
1-Year Change* | 46.96% |
Day's Range* | 181.35 - 183.41 |
52 wk Range | 113.69-160.36 |
Average Volume (10 days) | 438.11K |
Average Volume (3 months) | 10.44M |
Market Cap | 10.68B |
P/E Ratio | 16.41 |
Shares Outstanding | 68.26M |
Revenue | 14.03B |
EPS | 9.53 |
Dividend (Yield %) | 0.51154 |
Beta | 1.24 |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2024 | 182.26 | 1.56 | 0.86% | 180.70 | 183.49 | 180.22 |
Mar 27, 2024 | 181.71 | 3.43 | 1.92% | 178.28 | 181.79 | 176.95 |
Mar 26, 2024 | 177.13 | 0.54 | 0.31% | 176.59 | 179.26 | 176.32 |
Mar 25, 2024 | 177.71 | -2.29 | -1.27% | 180.00 | 180.22 | 177.34 |
Mar 22, 2024 | 180.33 | 0.80 | 0.45% | 179.53 | 180.97 | 178.27 |
Mar 21, 2024 | 180.59 | 1.28 | 0.71% | 179.31 | 182.16 | 179.23 |
Mar 20, 2024 | 179.75 | 1.04 | 0.58% | 178.71 | 180.59 | 177.96 |
Mar 19, 2024 | 180.04 | 3.93 | 2.23% | 176.11 | 180.87 | 176.01 |
Mar 18, 2024 | 177.08 | 4.18 | 2.42% | 172.90 | 177.50 | 171.22 |
Mar 15, 2024 | 173.83 | 3.80 | 2.23% | 170.03 | 174.51 | 170.03 |
Mar 14, 2024 | 172.80 | 0.06 | 0.03% | 172.74 | 173.53 | 171.63 |
Mar 13, 2024 | 174.31 | 1.24 | 0.72% | 173.07 | 176.76 | 173.07 |
Mar 12, 2024 | 174.53 | 4.40 | 2.59% | 170.13 | 174.84 | 169.36 |
Mar 11, 2024 | 171.12 | -1.58 | -0.91% | 172.70 | 174.86 | 170.37 |
Mar 8, 2024 | 175.60 | -0.77 | -0.44% | 176.37 | 177.73 | 175.60 |
Mar 7, 2024 | 177.53 | 2.39 | 1.36% | 175.14 | 179.04 | 174.79 |
Mar 6, 2024 | 175.84 | 2.22 | 1.28% | 173.62 | 177.05 | 172.63 |
Mar 5, 2024 | 175.36 | 2.59 | 1.50% | 172.77 | 177.35 | 172.77 |
Mar 4, 2024 | 174.43 | 5.13 | 3.03% | 169.30 | 175.35 | 169.30 |
Mar 1, 2024 | 171.03 | 4.69 | 2.82% | 166.34 | 171.74 | 165.06 |
Universal Health Services Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, April 23, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q1 2024 Universal Health Services Inc Earnings Release Q1 2024 Universal Health Services Inc Earnings ReleaseForecast -Previous - |
Thursday, May 16, 2024 | ||
Time (UTC) 14:00 | Country US
| Event Universal Health Services Inc Annual Shareholders Meeting Universal Health Services Inc Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 13399.4 | 12642.1 | 11558.9 | 11378.3 | 10772.3 |
Revenue | 13399.4 | 12642.1 | 11558.9 | 11378.3 | 10772.3 |
Total Operating Expense | 12395.8 | 11296 | 10200.5 | 10162.4 | 9597.02 |
Selling/General/Admin. Expenses, Total | 8368.22 | 7709.94 | 7017.29 | 6948.05 | 6529.28 |
Depreciation / Amortization | 581.861 | 533.213 | 510.493 | 490.392 | 453.045 |
Unusual Expense (Income) | 17 | ||||
Other Operating Expenses, Total | 3445.73 | 3035.87 | 2672.76 | 2723.91 | 2614.69 |
Operating Income | 1003.55 | 1346.09 | 1358.35 | 1215.91 | 1175.26 |
Interest Income (Expense), Net Non-Operating | -126.889 | -83.672 | -106.285 | -162.733 | -154.956 |
Net Income Before Taxes | 866.26 | 1293.31 | 1252.08 | 1066.34 | 1034.53 |
Net Income After Taxes | 656.982 | 987.632 | 952.79 | 827.543 | 791.883 |
Minority Interest | 18.627 | 3.958 | -8.837 | -12.689 | -18.178 |
Net Income Before Extra. Items | 675.609 | 991.59 | 943.953 | 814.854 | 773.705 |
Net Income | 675.609 | 991.59 | 943.953 | 814.854 | 779.705 |
Total Adjustments to Net Income | -0.748 | -2.059 | -2.981 | -2.028 | -1.091 |
Income Available to Common Excl. Extra. Items | 674.861 | 989.531 | 940.972 | 812.826 | 772.614 |
Income Available to Common Incl. Extra. Items | 674.861 | 989.531 | 940.972 | 812.826 | 778.614 |
Diluted Net Income | 674.861 | 989.531 | 940.972 | 812.826 | 778.614 |
Diluted Weighted Average Shares | 73.832 | 83.692 | 85.587 | 89.04 | 93.75 |
Diluted EPS Excluding Extraordinary Items | 9.14049 | 11.8235 | 10.9943 | 9.12877 | 8.24122 |
Dividends per Share - Common Stock Primary Issue | 0.8 | 0.2 | 0.6 | 0.4 | |
Diluted Normalized EPS | 9.14049 | 11.9786 | 10.9943 | 9.12877 | 8.24122 |
Total Extraordinary Items | 6 | ||||
Other, Net | -10.406 | 30.891 | 0.014 | 13.162 | 14.219 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total revenue | 3562.77 | 3548.14 | 3467.52 | 3446.98 | 3336.03 |
Revenue | 3562.77 | 3548.14 | 3467.52 | 3446.98 | 3336.03 |
Total Operating Expense | 3277.42 | 3268.01 | 3188.82 | 3185.6 | 3060.15 |
Selling/General/Admin. Expenses, Total | 2199 | 2185.95 | 2168.25 | 2117.57 | 2077.03 |
Depreciation / Amortization | 137.195 | 143.744 | 141.621 | 148.353 | 145.874 |
Other Operating Expenses, Total | 941.219 | 938.314 | 878.951 | 919.673 | 837.241 |
Operating Income | 285.357 | 280.128 | 278.7 | 261.384 | 275.88 |
Interest Income (Expense), Net Non-Operating | -53.378 | -48.831 | -50.876 | -43.887 | -35.653 |
Other, Net | -11.472 | -6.602 | -13.723 | 4.838 | -6.015 |
Net Income Before Taxes | 220.507 | 224.695 | 214.101 | 222.335 | 234.212 |
Net Income After Taxes | 168.008 | 169.302 | 162.375 | 170.369 | 176.811 |
Minority Interest | -1.019 | 2.011 | 0.74 | 4.451 | 6.003 |
Net Income Before Extra. Items | 166.989 | 171.313 | 163.115 | 174.82 | 182.814 |
Net Income | 166.989 | 171.313 | 163.115 | 174.82 | 182.814 |
Total Adjustments to Net Income | -0.052 | -0.061 | -0.129 | -0.156 | -0.179 |
Income Available to Common Excl. Extra. Items | 166.937 | 171.252 | 162.986 | 174.664 | 182.635 |
Income Available to Common Incl. Extra. Items | 166.937 | 171.252 | 162.986 | 174.664 | 182.635 |
Diluted Net Income | 166.937 | 171.252 | 162.986 | 174.664 | 182.635 |
Diluted Weighted Average Shares | 69.624 | 70.839 | 71.487 | 71.792 | 73.06 |
Diluted EPS Excluding Extraordinary Items | 2.39769 | 2.41748 | 2.27994 | 2.43292 | 2.49979 |
Dividends per Share - Common Stock Primary Issue | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Diluted Normalized EPS | 2.39769 | 2.41748 | 2.27994 | 2.43292 | 2.49979 |
Unusual Expense (Income) |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 2537.34 | 2263.56 | 3281.87 | 1915.93 | 1937.8 |
Cash and Short Term Investments | 102.818 | 115.301 | 1224.49 | 61.268 | 105.22 |
Cash & Equivalents | 102.818 | 115.301 | 1224.49 | 61.268 | 105.22 |
Total Receivables, Net | 2017.72 | 1746.64 | 1728.93 | 1560.85 | 1509.91 |
Accounts Receivable - Trade, Net | 2017.72 | 1746.64 | 1728.93 | 1560.85 | 1509.91 |
Total Inventory | 218.517 | 206.839 | 190.417 | 159.889 | 148.206 |
Other Current Assets, Total | 198.283 | 194.781 | 138.034 | 133.93 | 174.467 |
Total Assets | 13494.2 | 13093.5 | 13476.9 | 11668.2 | 11265.5 |
Property/Plant/Equipment, Total - Net | 6373.11 | 6241.75 | 5709.64 | 5343.22 | 4847.94 |
Property/Plant/Equipment, Total - Gross | 11540.5 | 11138.2 | 10222.4 | 9432.89 | 8563.46 |
Accumulated Depreciation, Total | -5167.39 | -4896.43 | -4512.76 | -4089.68 | -3715.51 |
Goodwill, Net | 3909.46 | 3962.62 | 3882.72 | 3869.76 | 3844.63 |
Other Long Term Assets, Total | 674.284 | 625.611 | 602.658 | 539.34 | 635.11 |
Total Current Liabilities | 1914.42 | 1984.11 | 2481.04 | 1563.39 | 1448.74 |
Accounts Payable | 636.601 | 658.9 | 570.523 | 446.957 | 445.652 |
Accrued Expenses | 1189.37 | 1266.07 | 1145.32 | 881.859 | 808.062 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 81.447 | 48.409 | 331.998 | 87.55 | 63.446 |
Other Current Liabilities, Total | 7.005 | 10.726 | 433.199 | 147.024 | 131.578 |
Total Liabilities | 7573.61 | 7003.88 | 7159.73 | 6164.15 | 5876.22 |
Total Long Term Debt | 4726.53 | 4141.88 | 3524.25 | 3896.58 | 3935.19 |
Long Term Debt | 4653.98 | 4065.29 | 3473.25 | 3880.22 | 3935.19 |
Deferred Income Tax | 0 | 5.582 | 25.071 | 49.661 | |
Minority Interest | 49.463 | 108.508 | 89.39 | 79.099 | 80.823 |
Other Liabilities, Total | 883.191 | 769.383 | 1059.47 | 600.008 | 361.809 |
Total Equity | 5920.58 | 6089.66 | 6317.15 | 5504.1 | 5389.26 |
Common Stock | 0.71 | 0.771 | 0.851 | 0.867 | 0.914 |
Retained Earnings (Accumulated Deficit) | 5929.54 | 6058.6 | 6268.17 | 5471.35 | 5384.11 |
Unrealized Gain (Loss) | 0 | ||||
Other Equity, Total | -9.668 | 30.291 | 48.12 | 31.893 | 4.242 |
Total Liabilities & Shareholders’ Equity | 13494.2 | 13093.5 | 13476.9 | 11668.2 | 11265.5 |
Total Common Shares Outstanding | 70.629 | 77.0911 | 85.0626 | 86.7066 | 91.3497 |
Capital Lease Obligations | 72.549 | 76.591 | 50.999 | 16.359 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 2753 | 2624.71 | 2559.1 | 2537.34 | 2456.56 |
Cash and Short Term Investments | 80.768 | 79.451 | 109.969 | 102.818 | 74.571 |
Cash & Equivalents | 80.768 | 79.451 | 109.969 | 102.818 | 74.571 |
Total Receivables, Net | 2234.34 | 2103.48 | 2032.18 | 2017.72 | 1902.47 |
Accounts Receivable - Trade, Net | 2234.34 | 2103.48 | 2032.18 | 2017.72 | 1902.47 |
Total Inventory | 214.587 | 215.38 | 216.236 | 218.517 | 217.818 |
Other Current Assets, Total | 223.303 | 226.405 | 200.71 | 198.283 | 261.698 |
Total Assets | 13873.5 | 13732.3 | 13556 | 13494.2 | 13378.9 |
Property/Plant/Equipment, Total - Net | 6530.98 | 6474.33 | 6412.33 | 6373.11 | 6393.61 |
Property/Plant/Equipment, Total - Gross | 11610.2 | 11441.6 | 11251.3 | 11540.5 | 11103.6 |
Accumulated Depreciation, Total | -5523.13 | -5413.89 | -5297.17 | -5167.39 | -5167.2 |
Goodwill, Net | 3912.12 | 3929.72 | 3913.91 | 3909.46 | 3874.02 |
Other Long Term Assets, Total | 677.37 | 703.539 | 670.624 | 674.284 | 654.713 |
Total Current Liabilities | 1989.81 | 2035.35 | 1863.38 | 1914.42 | 1939.2 |
Payable/Accrued | 1783.46 | 1843.38 | 1636.1 | 1795 | |
Accrued Expenses | 72.655 | 73.649 | 73.189 | 1189.37 | 70.146 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 126.555 | 111.357 | 96.235 | 81.447 | 66.307 |
Other Current Liabilities, Total | 7.145 | 6.962 | 57.858 | 7.005 | 7.743 |
Total Liabilities | 7808.56 | 7645.13 | 7543.85 | 7573.61 | 7523.55 |
Total Long Term Debt | 4796.07 | 4605.08 | 4707.32 | 4726.53 | 4638.36 |
Long Term Debt | 4796.07 | 4605.08 | 4707.32 | 4653.98 | 4638.36 |
Deferred Income Tax | |||||
Minority Interest | 46.287 | 45.79 | 44.578 | 49.463 | 53.29 |
Other Liabilities, Total | 976.379 | 958.915 | 928.568 | 883.191 | 892.701 |
Total Equity | 6064.92 | 6087.18 | 6012.11 | 5920.58 | 5855.35 |
Common Stock | 0.688 | 0.701 | 0.706 | 0.71 | 0.718 |
Retained Earnings (Accumulated Deficit) | 6074.5 | 6073.05 | 6016.45 | 5929.54 | 5852.61 |
Other Equity, Total | -10.276 | 13.429 | -5.046 | -9.668 | 2.022 |
Total Liabilities & Shareholders’ Equity | 13873.5 | 13732.3 | 13556 | 13494.2 | 13378.9 |
Total Common Shares Outstanding | 68.2587 | 69.3931 | 70.1818 | 70.629 | 71.4104 |
Accounts Payable | 636.601 | ||||
Capital Lease Obligations | 72.549 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 656.982 | 987.632 | 952.79 | 827.543 | 797.883 |
Cash From Operating Activities | 996.023 | 883.695 | 2360.17 | 1438.47 | 1274.74 |
Cash From Operating Activities | 581.861 | 533.213 | 510.493 | 490.392 | 453.076 |
Non-Cash Items | 143.512 | 99.738 | 69.159 | 159.522 | 116.105 |
Cash Taxes Paid | 250.759 | 362.978 | 286.247 | 260.622 | 293.837 |
Cash Interest Paid | 120.136 | 75.607 | 112.598 | 157.406 | 150.293 |
Changes in Working Capital | -386.332 | -736.888 | 827.727 | -38.988 | -92.322 |
Cash From Investing Activities | -647.296 | -914.466 | -802.562 | -688.41 | -747.247 |
Capital Expenditures | -734.001 | -855.659 | -734.209 | -655.513 | -701.205 |
Other Investing Cash Flow Items, Total | 86.705 | -58.807 | -68.353 | -32.897 | -46.042 |
Cash From Financing Activities | -318.4 | -1068.95 | -384.859 | -845.036 | -492.202 |
Financing Cash Flow Items | -57.055 | -12.657 | -12.146 | -14.413 | -28.382 |
Total Cash Dividends Paid | -58.449 | -65.896 | -17.344 | -53.003 | -37.342 |
Issuance (Retirement) of Stock, Net | -818.85 | -1207.5 | -194.401 | -759.698 | -387.229 |
Issuance (Retirement) of Debt, Net | 615.954 | 217.106 | -160.968 | -17.922 | -39.249 |
Foreign Exchange Effects | -8.424 | -0.499 | 0.739 | 0.959 | -2.905 |
Net Change in Cash | 21.903 | -1100.22 | 1173.49 | -94.018 | 32.388 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 162.375 | 656.982 | 486.613 | 309.802 | 151.021 |
Cash From Operating Activities | 290.753 | 996.023 | 698.719 | 478.047 | 445.433 |
Cash From Operating Activities | 141.621 | 581.861 | 433.508 | 287.634 | 143.784 |
Non-Cash Items | 20.669 | 143.512 | 63.325 | 42.724 | 20.139 |
Cash Taxes Paid | 2.36 | 250.759 | 182.091 | 145.448 | 4.423 |
Cash Interest Paid | 50.279 | 120.136 | 78.992 | 43.796 | 20.388 |
Changes in Working Capital | -33.912 | -386.332 | -284.727 | -162.113 | 130.489 |
Cash From Investing Activities | -178.311 | -647.296 | -398.906 | -325.58 | -168.96 |
Capital Expenditures | -168.752 | -734.001 | -569.555 | -407.962 | -200.002 |
Other Investing Cash Flow Items, Total | -9.559 | 86.705 | 170.649 | 82.382 | 31.042 |
Cash From Financing Activities | -105.891 | -318.4 | -303.027 | -124.033 | -278.039 |
Financing Cash Flow Items | -4.437 | -57.055 | -57.056 | -9.017 | -6.596 |
Total Cash Dividends Paid | -14.214 | -58.449 | -44.192 | -29.641 | -14.875 |
Issuance (Retirement) of Stock, Net | -82.051 | -818.85 | -712.985 | -558.521 | -362.002 |
Issuance (Retirement) of Debt, Net | -5.189 | 615.954 | 511.206 | 473.146 | 105.434 |
Foreign Exchange Effects | 1.65 | -8.424 | -10.339 | -5.457 | -2.232 |
Net Change in Cash | 8.201 | 21.903 | -13.553 | 22.977 | -3.798 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ursal Health Company profile
About Universal Health Services, Inc.
Universal Health Services, Inc. is a holding company. The Company operates through its subsidiaries including its management company. Its principal business activity is owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company's segments include acute care hospital services, behavioral health services and others. It offers approximately 360 inpatient facilities and 39 outpatient and other facilities located in United States, Washington, D.C., the United Kingdom and Puerto Rico. The services provided by its hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides management services to its facilities, including information services, finance and control systems, physician recruitment services, administrative personnel management and marketing.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Universal Health Services, Inc. revenues increased 9% to $12.64B. Net income applicable to common stockholders increased 5% to $989.5M. Revenues reflect Acute Care Hospital Services segment increase of 12% to $7.11B, Utilization of Licensed Beds -%,ACH increase of 6% to 65.5%, Patient Days - ACH increase of 8% to 1.6M. Net income was partially offset by Salaries.
Equity composition
Class B Common $.005 Par, 04/11, 150M auth., 90,330,760 issd. Insiders own 1.50%. Class A $.005 Par, 12M auth., 6,656,808 issd., Class C $.01 Par, 1.2M auth., 665,400 issd., Class D $.005 Par, 5M auth., 35,218 issd. 12/09, 2-for-1 stock split.
Industry: | Healthcare Facilities & Services (NEC) |
367 S Gulph Rd
KING OF PRUSSIA
PENNSYLVANIA 19406
US
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com